Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters
Authors:
- J. CaseyJCJ. Casey
- C. LiCLC. Li
- A. V. CroweACA. V. Crowe
- P. McClellandPMP. McClelland
- 6 December 2004
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 29 (6) , 517-520
Abstract
Problem: Urokinase and streptokinase are commonly used thrombolytic agents for obstructed central venous catheters. Although proven to be efficacious, these agents have the potential to induce fibrin breakdown and streptokinase cannot be used repeatedly because of its allergenic nature. Published evidence suggests that Urokinase is safe and effective (>70% efficacy for catheter installation) and that Tissue-type plasminogen activator (rt-PA) can achieve as much as 98% success. Objective: To describe our experience with and our protocol for the use of rt-PA as an alternative agent for catheter thrombolysis. Design: Investigation of a cohort of haemodialysis patients with tunnelled central venous catheter (SPCVC) placed between December 2001 to August 2003 and who developed catheter thrombus (female, n = 8: male, n = 12). Each patient was given an infusion of between 1 and 2 mg rt-PA/h for 4 h. The dose was dependent on partial or total line obstruction. The technical success of rt-PA is defined as returning catheter blood flow to >250 mL/min for a 4-h period. Findings: Twenty patients required 57 infusions in 38 lumens between 01/01/02 to 01/09/03. For completely blocked lines rt-PA was infused at 2 mg/h for 4 h achieving 85% success rate. For inadequate flow (<250 mL/min) rt-PA was infused at 1 mg/h for 4 h achieving an 88% success rate. Conclusion: Rt-PA administered at 2 mg/h for blocked lines effectively restores haemodialysis catheter patency, and at 1 mg/h for sluggish lines is also effective in restoring blood flow through catheters.Keywords
This publication has 12 references indexed in Scilit:
- Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosisAmerican Journal of Health-System Pharmacy, 2002
- Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access DevicesJournal of Clinical Oncology, 2002
- A protocol of urokinase infusion and warfarin for the management of the thrombosed haemodialysis catheterNephrology Dialysis Transplantation, 2001
- Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Flow in Occluded Central Venous Access Devices: A Double-Blind Placebo-Controlled Trial—The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy TrialJournal of Vascular and Interventional Radiology, 2001
- Treatment of Hemodialysis Catheter–associated Fibrin Sheaths by rt-PA Infusion: Critical Analysis of 124 ProceduresJournal of Vascular and Interventional Radiology, 2001
- Thrombolysis for Restoration of Patency to Haemodialysis Central Venous Catheters: A Systematic ReviewJournal of Thrombosis and Thrombolysis, 2001
- Efficacy of tissue plasminogen activator administration on patency of hemodialysis access cathetersAmerican Journal of Kidney Diseases, 2000
- High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis cathetersAmerican Journal of Kidney Diseases, 1998
- Adequacy of haemodialysis with cuffed central-vein cathetersNephrology Dialysis Transplantation, 1998
- Fibrin Sleeve Formation on Indwelling Subclavian Central Venous CathetersArchives of Surgery, 1971